SCHEMBL29133371

SCHEMBL29133371

Cc1cc(Cl)c2cnn(C)c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 4/20 0.47
KMT2A Q03164 9/20 0.43
MEN1 O00255 7/20 0.43
HCRTR1 O43613 1/20 0.43
MAPT P10636 4/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KCNH2 Q12809 1/20 0.39
TLR8 Q9NR97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL561004 0.83 PDE2A (0.49) PDE2AKMT2AMEN1HCRTR1MAPT
SCHEMBL29467448 0.83 PDE2A (0.49) PDE2AKMT2AMEN1HCRTR1MAPT
SCHEMBL23872469 0.81 PDE2A (0.42) PDE2AKMT2AMEN1HCRTR1KDM4E
SCHEMBL19953345 0.79 MAPT (0.49) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL29786728 0.79 MAPT (0.49) KMT2AMEN1MAPTKDM4EALDH1A1
SCHEMBL19953294 0.78 KMT2A (0.40) PDE2AKMT2AMEN1HCRTR1MAPT
SCHEMBL20674220 0.78 PDE2A (0.40) PDE2AKMT2AMEN1HCRTR1MAPT
SCHEMBL30899643 0.78 PDE2A (0.40) PDE2AKMT2AMEN1ALDH1A1KCNH2
SCHEMBL24654997 0.78 KMT2A (0.41) PDE2AKMT2AMEN1HCRTR1MAPT
SCHEMBL30935932 0.78 PDE2A (0.40) PDE2AKMT2AMEN1HCRTR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076604-A Pyrazolo [3,4-b ] pyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2024-05-24 CN disclosed
EP-4182032-A1 HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2023-05-24 EP disclosed
CN-115835910-A Hydrogenated isoquinoline or naphthyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2023-03-21 CN disclosed